246 related articles for article (PubMed ID: 29688280)
21. Hyperprolactinemia and association with prolactinoma in transwomen receiving gender affirming hormone treatment.
Raven LM; Guttman-Jones M; Muir CA
Endocrine; 2021 May; 72(2):524-528. PubMed ID: 33398769
[TBL] [Abstract][Full Text] [Related]
22. Gender incongruence and the brain - Behavioral and neural correlates of voice gender perception in transgender people.
Smith E; Junger J; Pauly K; Kellermann T; Neulen J; Neuschaefer-Rube C; Derntl B; Habel U
Horm Behav; 2018 Sep; 105():11-21. PubMed ID: 29981752
[TBL] [Abstract][Full Text] [Related]
23. Pituitary Adenomas in Transgender Individuals?
Kleinschmidt-DeMasters BK
J Neuropathol Exp Neurol; 2020 Jan; 79(1):62-66. PubMed ID: 31769844
[TBL] [Abstract][Full Text] [Related]
24. Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI).
Cocchetti C; Castellini G; Iacuaniello D; Romani A; Maggi M; Vignozzi L; Schreiner T; den Heijer M; T'Sjoen G; Fisher AD
J Sex Med; 2021 Apr; 18(4):821-829. PubMed ID: 33745831
[TBL] [Abstract][Full Text] [Related]
25. Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study.
Weill A; Nguyen P; Labidi M; Cadier B; Passeri T; Duranteau L; Bernat AL; Yoldjian I; Fontanel S; Froelich S; Coste J
BMJ; 2021 Feb; 372():n37. PubMed ID: 33536184
[TBL] [Abstract][Full Text] [Related]
26. Hormonal Treatment and Cardiovascular Risk Profile in Transgender Adolescents.
Klaver M; de Mutsert R; van der Loos MATC; Wiepjes CM; Twisk JWR; den Heijer M; Rotteveel J; Klink DT
Pediatrics; 2020 Mar; 145(3):. PubMed ID: 32102929
[TBL] [Abstract][Full Text] [Related]
27. Prostate Cancer Incidence under Androgen Deprivation: Nationwide Cohort Study in Trans Women Receiving Hormone Treatment.
de Nie I; de Blok CJM; van der Sluis TM; Barbé E; Pigot GLS; Wiepjes CM; Nota NM; van Mello NM; Valkenburg NE; Huirne J; Gooren LJG; van Moorselaar RJA; Dreijerink KMA; den Heijer M
J Clin Endocrinol Metab; 2020 Sep; 105(9):e3293-9. PubMed ID: 32594155
[TBL] [Abstract][Full Text] [Related]
28. Bone Mineral Density Increases in Trans Persons After 1 Year of Hormonal Treatment: A Multicenter Prospective Observational Study.
Wiepjes CM; Vlot MC; Klaver M; Nota NM; de Blok CJ; de Jongh RT; Lips P; Heijboer AC; Fisher AD; Schreiner T; T'Sjoen G; den Heijer M
J Bone Miner Res; 2017 Jun; 32(6):1252-1260. PubMed ID: 28370342
[TBL] [Abstract][Full Text] [Related]
29. Mortality trends over five decades in adult transgender people receiving hormone treatment: a report from the Amsterdam cohort of gender dysphoria.
de Blok CJ; Wiepjes CM; van Velzen DM; Staphorsius AS; Nota NM; Gooren LJ; Kreukels BP; den Heijer M
Lancet Diabetes Endocrinol; 2021 Oct; 9(10):663-670. PubMed ID: 34481559
[TBL] [Abstract][Full Text] [Related]
30. MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people.
Glintborg D; T'Sjoen G; Ravn P; Andersen MS
Eur J Endocrinol; 2021 Jun; 185(2):R49-R63. PubMed ID: 34081614
[TBL] [Abstract][Full Text] [Related]
31. Is there a need for liver enzyme monitoring in people using gender-affirming hormone therapy?
Stangl TA; Wiepjes CM; Defreyne J; Conemans E; D Fisher A; Schreiner T; T'Sjoen G; den Heijer M
Eur J Endocrinol; 2021 Apr; 184(4):513-520. PubMed ID: 33524005
[TBL] [Abstract][Full Text] [Related]
32. Five new cases of breast cancer in transsexual persons.
Gooren L; Bowers M; Lips P; Konings IR
Andrologia; 2015 Dec; 47(10):1202-5. PubMed ID: 25611459
[TBL] [Abstract][Full Text] [Related]
33. People with gender dysphoria who self-prescribe cross-sex hormones: prevalence, sources, and side effects knowledge.
Mepham N; Bouman WP; Arcelus J; Hayter M; Wylie KR
J Sex Med; 2014 Dec; 11(12):2995-3001. PubMed ID: 25213018
[TBL] [Abstract][Full Text] [Related]
34. Systematic Review of the Long-Term Effects of Transgender Hormone Therapy on Bone Markers and Bone Mineral Density and Their Potential Effects in Implant Therapy.
Delgado-Ruiz R; Swanson P; Romanos G
J Clin Med; 2019 Jun; 8(6):. PubMed ID: 31159456
[TBL] [Abstract][Full Text] [Related]
35. Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons: A Cohort Study.
Getahun D; Nash R; Flanders WD; Baird TC; Becerra-Culqui TA; Cromwell L; Hunkeler E; Lash TL; Millman A; Quinn VP; Robinson B; Roblin D; Silverberg MJ; Safer J; Slovis J; Tangpricha V; Goodman M
Ann Intern Med; 2018 Aug; 169(4):205-213. PubMed ID: 29987313
[TBL] [Abstract][Full Text] [Related]
36. New Insights Into Extended Steroid Hormone Profiles in Transwomen in a Multi-Center Setting in Germany.
Schneider F; Wistuba J; Holterhus PM; Kulle A; Schlatt S; Kliesch S; Neuhaus N; Zitzmann M
J Sex Med; 2021 Oct; 18(10):1807-1817. PubMed ID: 34600646
[TBL] [Abstract][Full Text] [Related]
37. Changes of Vitamin D-Binding Protein, and Total, Bioavailable, and Free 25-Hydroxyvitamin D in Transgender People.
Chen H; Wiepjes CM; van Schoor NM; Heijboer AC; de Jongh RT; den Heijer M; Lips P
J Clin Endocrinol Metab; 2019 Jul; 104(7):2728-2734. PubMed ID: 30785996
[TBL] [Abstract][Full Text] [Related]
38. Incidence of hypertension in young transgender people after a 5-year follow-up: association with gender-affirming hormonal therapy.
Martinez-Martin FJ; Kuzior A; Hernandez-Lazaro A; de Leon-Durango RJ; Rios-Gomez C; Santana-Ojeda B; Perez-Rivero JM; Fernandez-Trujillo-Comenge PM; Gonzalez-Diaz P; Arnas-Leon C; Acosta-Calero C; Perdomo-Herrera E; Tocino-Hernandez AL; Del Sol Sanchez-Bacaicoa M; Del Pino Perez-Garcia M
Hypertens Res; 2023 Jan; 46(1):219-225. PubMed ID: 36229533
[TBL] [Abstract][Full Text] [Related]
39. Risk for Venous Thromboembolism in Transgender Patients Undergoing Cross-Sex Hormone Treatment: A Systematic Review.
Kotamarti VS; Greige N; Heiman AJ; Patel A; Ricci JA
J Sex Med; 2021 Jul; 18(7):1280-1291. PubMed ID: 34140253
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular implications of gender-affirming hormone treatment in the transgender population.
Dutra E; Lee J; Torbati T; Garcia M; Merz CNB; Shufelt C
Maturitas; 2019 Nov; 129():45-49. PubMed ID: 31547912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
